Pharmacokinetics and pharmacodynamics of a chimeric interleukin-2 receptor monoclonal antibody, basiliximab, in renal transplantation: a comparison between Japanese and non-Japanese patients

By Haba T.   Uchida K.   Katayama A.   Tominaga Y.   Sato T.   Watanabe I.   Inagaki H.   Kimata T.   Goto K.   Morozumi K.   Takeda A.   Takahara S.   Takahashi K.   Oshima S.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3174-3175

Elsevier

Access to resources Recommend Favorite

Induction immunosuppression with interleukin-2 receptor antibodies (basiliximab and daclizumab) in renal transplant recipients

By Nair M.P.   Nampoory M.R.N.   Johny K.V.   Costandi J.N.   Abdulhalim M.   El-Reshaid W.   Al-Muzairai I.   Ninan V.T.   Samhan M.   Al-Mousawi M.  

Transplantation Proceedings, Vol. 33, Iss. 5, 2001-08 ,pp. : 2767-2769

Elsevier

Access to resources Recommend Favorite

Immunoprophylaxis with simulect (Basiliximab) in pediatric kidney transplant recipients: results from routine clinical practice at 5 kidney transplant units

By Garcia Meseguer C.   Vila Lopez A.   Luque de Pablos A.   Vallo Boado A.   Simon J.M.   Pediatric EOSS Study Group  

Transplantation Proceedings, Vol. 35, Iss. 5, 2003-08 ,pp. : 1697-1698

Elsevier

Access to resources Recommend Favorite

Rescue Therapy with Interleukin-2 Receptor Antibody in High Risk Kidney Transplant Patients: A 3-Year Follow-Up Study

By Carl S.   Wiesel M.   Daniel V.   Dorsam J.   Opelz G.   Staehler G.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 320-322

Elsevier

Access to resources Recommend Favorite

Bolus anti-thymocyte globulin induction in renal transplant recipients: a comparison with conventional ATG or anti-interleukin-2 receptor antibody induction

By Nampoory M.R.N.   Abdulhalim M.   Johny K.V.   Al-Jawad Donia F.A.   Nair M.P.   Said T.   Homoud H.   Samhan M.   Al-Mousawi M.  

Transplantation Proceedings, Vol. 34, Iss. 7, 2002-11 ,pp. : 2916-2919

Elsevier

Access to resources Recommend Favorite